Forgive my naiveté, but we have delved deeply int
Post# of 32972
(Total Views: 402)
Posted On: 11/17/2018 10:31:36 AM
Forgive my naiveté, but we have delved deeply into who current and potential partners for several of our products will and could be, but I haven't seen much recent discussion about potential partners for NotifiMed. With Rory having said NotifiMed has bumped up to number one in terms of nFusz product potential, I wanted to try and learn a bit more about it and where we could reap the revenue.
Correct me if I am wrong, but in terms of partnering the product for use in clinical trials, instead of going after the individual pharma and biopharma companies that are developing the drugs, it makes more sense to go after the companies administering the clinical trials. That would be the Contract Research Organizations (CRO's). They are the ones working with multiple pharma at the same time, they are the ones that have to market themselves to be more efficient and provide a more efficient/cost effective/results driven product to their customers, and obviously we believe NotifiMed will help in that regard. It may be more sexy to have an 8K saying we are partnering with Pfizer or Novartis or Sanofi, but there is much more meat and potatoes if we sign a CRO. Reminds me of the joke where a young bull is sitting with his father overlooking a group of cows. The young bull says Dad, let's run down and have our way with one of the cows. The father bull says, no, let's walk down a have our way with all the cows.
Maybe this is the moment where you all say "No Duh". If so, please let me have my Come to Jesus Moment without ridicule.
Below is a list of top CRO's from Wikipedia. I think Redspeed or someone else mentioned there have been clues, but I am a bit daft when it comes to recognizing clues and need to be hit on the head. We get in bed with any of the below, and demonstrate we offer a more efficient and cost effective way to collect patient data, and I am sure we soon become partners with a majority of them, if Rory continues his abilities to sign non-exclussive deals. The below companies are cash machines and considered a necessary evil by the pharma as they try to become leaner and outsource everything in a move towards becoming virtual companies.
Anyway, just thought it would make for good discussion.
List of companies by annual revenue
As of 2016, there was a 15.5% increase in R&D spending from 2015 to 2020. As of 2017, IgeaHub considered the top CROs by revenue to be]
- Laboratory Corporation of America Holdings (Covance) ($10.44B revenues in 2017)
- IQVIA ($9.74B revenues in 2017)
- Syneos Health ($2.67B revenues in 2017)
- PAREXEL International Corporation ($2.44B revenues in 2017)
- PRA Health Sciences ($2.26B revenues in 2017)
- Pharmaceutical Product Development (PPD) ($1.90B revenues in 2017)
- Charles River Laboratories International Inc (CRL) ($1.86B revenues in 2017)
- ICON Public Limited Corporation ($1.76B revenues in 2017)
- Wuxi Apptec ($1.01B revenues in 2017)
- Medpace Holdings, Inc ($0.44B revenues in 2017)
Correct me if I am wrong, but in terms of partnering the product for use in clinical trials, instead of going after the individual pharma and biopharma companies that are developing the drugs, it makes more sense to go after the companies administering the clinical trials. That would be the Contract Research Organizations (CRO's). They are the ones working with multiple pharma at the same time, they are the ones that have to market themselves to be more efficient and provide a more efficient/cost effective/results driven product to their customers, and obviously we believe NotifiMed will help in that regard. It may be more sexy to have an 8K saying we are partnering with Pfizer or Novartis or Sanofi, but there is much more meat and potatoes if we sign a CRO. Reminds me of the joke where a young bull is sitting with his father overlooking a group of cows. The young bull says Dad, let's run down and have our way with one of the cows. The father bull says, no, let's walk down a have our way with all the cows.
Maybe this is the moment where you all say "No Duh". If so, please let me have my Come to Jesus Moment without ridicule.
Below is a list of top CRO's from Wikipedia. I think Redspeed or someone else mentioned there have been clues, but I am a bit daft when it comes to recognizing clues and need to be hit on the head. We get in bed with any of the below, and demonstrate we offer a more efficient and cost effective way to collect patient data, and I am sure we soon become partners with a majority of them, if Rory continues his abilities to sign non-exclussive deals. The below companies are cash machines and considered a necessary evil by the pharma as they try to become leaner and outsource everything in a move towards becoming virtual companies.
Anyway, just thought it would make for good discussion.
List of companies by annual revenue
As of 2016, there was a 15.5% increase in R&D spending from 2015 to 2020. As of 2017, IgeaHub considered the top CROs by revenue to be]
- Laboratory Corporation of America Holdings (Covance) ($10.44B revenues in 2017)
- IQVIA ($9.74B revenues in 2017)
- Syneos Health ($2.67B revenues in 2017)
- PAREXEL International Corporation ($2.44B revenues in 2017)
- PRA Health Sciences ($2.26B revenues in 2017)
- Pharmaceutical Product Development (PPD) ($1.90B revenues in 2017)
- Charles River Laboratories International Inc (CRL) ($1.86B revenues in 2017)
- ICON Public Limited Corporation ($1.76B revenues in 2017)
- Wuxi Apptec ($1.01B revenues in 2017)
- Medpace Holdings, Inc ($0.44B revenues in 2017)
(15)
(0)